What's in Veradermics, Inc.'s pipeline?

Veradermics, Inc. has 5 drugs in our index: 0 marketed, 0 filed, 3 in Phase 3, 2 in Phase 2, 0 in Phase 1.

Which companies overlap with Veradermics, Inc.'s portfolio?

Top competitors by shared drug class: Ironshore Pharmaceuticals and Development, Inc, Jiangsu HengRui Medicine Co., Ltd., Melinta Therapeutics, Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/veradermics-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Veradermics, Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Veradermics, Inc. pipeline: 0 marketed, 0 filed, 3 Phase 3, 2 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 3 Phase 3 2 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
VDPHL01	VDPHL01	phase 3	HDAC inhibitor	H3 histone deacetylase (HDAC)	Oncology
VDPHL01 BID	VDPHL01 BID	phase 3	H3 receptor antagonist	H3 histamine receptor	Sleep disorders
VDPHL01 QD	VDPHL01 QD	phase 3	HDAC inhibitor	H3 histone deacetylase (HDAC)	Inflammatory diseases

Therapeutic area mix

Inflammatory diseases · 1
Oncology · 1
Sleep disorders · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Ironshore Pharmaceuticals and Development, Inc · 1 shared drug class
Jiangsu HengRui Medicine Co., Ltd. · 1 shared drug class
Melinta Therapeutics, Inc. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Veradermics, Inc.:

Cite this brief

Drug Landscape (2026). Veradermics, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/veradermics-inc. Accessed 2026-06-10.